Ticker
Drug firm and EU conclude talks on vaccine
By EUobserver
The American biotechnology company Moderna said Monday it had concluded advanced talks with the EU to supply 80 million doses of its Covid-19 vaccine candidate, which is currently in late-stage testing, Reuters reported. The potential agreement provides for an option for EU countries to buy an additional 80 million doses. Moderna is the fifth company with which the EU has concluded talks in an effort to secure a Covid-19 vaccine.